Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-BCMA chimeric antigen receptors

Anti-BCMA chimeric antigen receptors

US Patent 11999773 · Granted Jun 4, 2024

Estimated economic value: $14,734,000 ⓘ

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chimeric antigen receptors with enhanced signaling and activities and uses there2025
Anti-coronavirus antibodies and methods of use2024
Assay devices for combinatorial libraries2024
Caps for assay devices2024
DLL3 targeting chimeric antigen receptors and binding agents2023
Anti-coronavirus antibodies and methods of use2022
Anti-coronavirus antibodies and methods of use2022
Anti-PD-L1-anti-TIM-3 bispecific antibodies2022
Anti-Tim-3 antibodies for combination with anti-PD-1 antibodies2022
Methods of quantifying target nucleic acids and identifying sequence variants2022
Assay devices for combinatorial libraries2022
Anti-BCMA chimeric antigen receptors2022